UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): August 15, 2011
INSMED INCORPORATED
(Exact Name of Registrant as Specified in Its Charter)
Virginia
(State or Other Jurisdiction of Incorporation)
| 0-30739 | 54-1972729 | |
| (Commission File Number) |
(IRS Employer Identification No.) | |
| 11 Deer Park Drive, Suite 117, Monmouth Junction, NJ | 08852 | |
| (Address of Principal Executive Offices) | (Zip Code) | |
(732) 438-9434
(Registrant’s Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
INFORMATION TO BE INCLUDED IN THE REPORT
| Item 7.01 | Regulation FD Disclosure. |
In August 2011, Insmed Incorporated updated the Company’s Investor Presentation. Our Chief Executive Officer and President, Timothy Whitten will present some or all of the August 2011 Investor Presentation to various investors during the month of August 2011. A copy of the presentation materials is furnished as Exhibit 99.1 hereto and is incorporated herein by reference. Mr. Whitten is scheduled to give a summary of this presentation at 8:00 a.m. ET on Tuesday August16, 2011 at the Wedbush Securities Life Sciences Management Access Conference (the “Conference”) which will be held in New York, NY.
An audio feed of the presentation at the Conference will be simultaneously webcast on Insmed’s web site at http://www.insmed.com and archived for future review until on or about ninety days after the Conference. The presentation materials will be available on Insmed’s web site and archived for future review.
| Item 9.01 | Financial Statements and Exhibits |
(d) Exhibits
| Exhibit No. | Description | |
| 99.1 | August 2011 Investor Presentation | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Insmed Incorporated
Date: August 15, 2011
| By: /s/ Kevin P. Tully, C.G.A. | ||
| Name: | Kevin P. Tully, C.G.A. | |
| Title: | Executive Vice President & Chief Financial Officer | |
EXHIBIT INDEX
| Exhibit No. |
Description | |
| 99.1 |
August 2011 Investor Presentation | |